COSMOS HEALTH INC (COSM) Stock Fundamental Analysis

NASDAQ:COSM • US2214133058

0.3763 USD
-0.02 (-5.88%)
At close: Feb 19, 2026
0.3838 USD
+0.01 (+1.99%)
After Hours: 2/19/2026, 5:51:35 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

COSM gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. COSM has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, COSM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year COSM has reported negative net income.
  • COSM had a negative operating cash flow in the past year.
  • In the past 5 years COSM reported 4 times negative net income.
  • COSM had a negative operating cash flow in each of the past 5 years.
COSM Yearly Net Income VS EBIT VS OCF VS FCFCOSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • COSM's Return On Assets of -26.68% is on the low side compared to the rest of the industry. COSM is outperformed by 83.33% of its industry peers.
  • The Return On Equity of COSM (-80.15%) is worse than 75.49% of its industry peers.
Industry RankSector Rank
ROA -26.68%
ROE -80.15%
ROIC N/A
ROA(3y)-58.08%
ROA(5y)-40.78%
ROE(3y)-108%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COSM Yearly ROA, ROE, ROICCOSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

1.3 Margins

  • The Gross Margin of COSM (11.41%) is worse than 72.55% of its industry peers.
  • In the last couple of years the Gross Margin of COSM has declined.
  • COSM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.83%
GM growth 5Y-3%
COSM Yearly Profit, Operating, Gross MarginsCOSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • COSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, COSM has more shares outstanding
  • The number of shares outstanding for COSM has been increased compared to 5 years ago.
  • COSM has a worse debt/assets ratio than last year.
COSM Yearly Shares OutstandingCOSM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
COSM Yearly Total Debt VS Total AssetsCOSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • COSM has an Altman-Z score of -2.11. This is a bad value and indicates that COSM is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.11, COSM is doing worse than 84.31% of the companies in the same industry.
  • A Debt/Equity ratio of 0.55 indicates that COSM is somewhat dependend on debt financing.
  • COSM has a Debt to Equity ratio of 0.55. This is comparable to the rest of the industry: COSM outperforms 59.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z -2.11
ROIC/WACCN/A
WACC6.65%
COSM Yearly LT Debt VS Equity VS FCFCOSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • COSM has a Current Ratio of 0.99. This is a bad value and indicates that COSM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.99, COSM is not doing good in the industry: 71.57% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.84 indicates that COSM may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.84, COSM is doing worse than 72.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.84
COSM Yearly Current Assets VS Current LiabilitesCOSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 68.03% over the past year.
  • Looking at the last year, COSM shows a small growth in Revenue. The Revenue has grown by 6.69% in the last year.
  • The Revenue has been growing slightly by 6.52% on average over the past years.
EPS 1Y (TTM)68.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.57%
Revenue 1Y (TTM)6.69%
Revenue growth 3Y-1.09%
Revenue growth 5Y6.52%
Sales Q2Q%37.86%

3.2 Future

  • COSM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.85% yearly.
  • COSM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.72% yearly.
EPS Next Y56.41%
EPS Next 2Y36.34%
EPS Next 3Y27.85%
EPS Next 5YN/A
Revenue Next Year17.73%
Revenue Next 2Y34.26%
Revenue Next 3Y33.72%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
COSM Yearly Revenue VS EstimatesCOSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
COSM Yearly EPS VS EstimatesCOSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for COSM. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for COSM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COSM Price Earnings VS Forward Price EarningsCOSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COSM Per share dataCOSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • COSM's earnings are expected to grow with 27.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.34%
EPS Next 3Y27.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for COSM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

COSMOS HEALTH INC

NASDAQ:COSM (2/19/2026, 5:51:35 PM)

After market: 0.3838 +0.01 (+1.99%)

0.3763

-0.02 (-5.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-18
Earnings (Next)04-13
Inst Owners3.48%
Inst Owner Change21.88%
Ins Owners25.97%
Ins Owner Change17.62%
Market Cap13.14M
Revenue(TTM)59.79M
Net Income(TTM)-18.54M
Analysts82.86
Price TargetN/A
Short Float %0.43%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.49%
Min Revenue beat(2)-17.28%
Max Revenue beat(2)2.29%
Revenue beat(4)1
Avg Revenue beat(4)-8.02%
Min Revenue beat(4)-17.28%
Max Revenue beat(4)2.29%
Revenue beat(8)2
Avg Revenue beat(8)-6.13%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)-3500%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.05%
Revenue NY rev (1m)-5.81%
Revenue NY rev (3m)-5.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.87
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS1.71
BVpS0.66
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.68%
ROE -80.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.41%
FCFM N/A
ROA(3y)-58.08%
ROA(5y)-40.78%
ROE(3y)-108%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.83%
GM growth 5Y-3%
F-Score3
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 155.57%
Cap/Sales 3.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.84
Altman-Z -2.11
F-Score3
WACC6.65%
ROIC/WACCN/A
Cap/Depr(3y)584.69%
Cap/Depr(5y)410.56%
Cap/Sales(3y)5.71%
Cap/Sales(5y)3.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.57%
EPS Next Y56.41%
EPS Next 2Y36.34%
EPS Next 3Y27.85%
EPS Next 5YN/A
Revenue 1Y (TTM)6.69%
Revenue growth 3Y-1.09%
Revenue growth 5Y6.52%
Sales Q2Q%37.86%
Revenue Next Year17.73%
Revenue Next 2Y34.26%
Revenue Next 3Y33.72%
Revenue Next 5YN/A
EBIT growth 1Y30.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.44%
OCF growth 3YN/A
OCF growth 5YN/A

COSMOS HEALTH INC / COSM FAQ

Can you provide the ChartMill fundamental rating for COSMOS HEALTH INC?

ChartMill assigns a fundamental rating of 1 / 10 to COSM.


What is the valuation status of COSMOS HEALTH INC (COSM) stock?

ChartMill assigns a valuation rating of 1 / 10 to COSMOS HEALTH INC (COSM). This can be considered as Overvalued.


Can you provide the profitability details for COSMOS HEALTH INC?

COSMOS HEALTH INC (COSM) has a profitability rating of 0 / 10.


How financially healthy is COSMOS HEALTH INC?

The financial health rating of COSMOS HEALTH INC (COSM) is 0 / 10.